Correcting and replacing - hepion pharmaceuticals, inc.

Edison, n.j., may 27, 2022 (globe newswire) -- in the press release issued earlier today by hepion pharmaceuticals, inc. (nasdaq:hepa), we've been informed by the company that in both the headline and first paragraph the name 'recofilstat' should be 'rencofilstat'. completed corrected text follows.

HEPA Ratings Summary

HEPA Quant Ranking